209-400-1

Applied Filters:

Keyword:'209-400-1'

Showing 1-5 of 5 results for "209-400-1" within Papers

Rate coefficients for reactions of OH and Cl with esters.

Peng Liang et al.

Chemphyschem : a European journal of chemical physics and physical chemistry, 11(18), 4097-4102 (2010-08-19)

Rate coefficients for the gas-phase reactions of OH radicals with n-propyl butyrate (k(1)), n-butyl propionate (k(2)) and n-butyl butyrate (k(3)) are measured by both absolute and relative methods. The kinetics data obtained over the temperature range 273-372 K are used

Gonadotropin releasing hormone binding sites in human epithelial ovarian carcinomata.

G Emons et al.

European journal of cancer & clinical oncology, 25(2), 215-221 (1989-02-01)

As a first step to investigate whether gonadotropin releasing hormone (GnRH) analogs might be able to modulate directly the proliferation of human epithelial ovarian carcinomata, we checked if binding sites for GnRH are present in these malignancies. Specific binding of

Evaluation of different adsorbents for large-volume pre-concentration for analyzing atmospheric persistent organic pollutants at trace levels.

Pasquale Avino et al.

Analytical and bioanalytical chemistry, 400(10), 3561-3571 (2011-05-10)

This paper investigates the performance of some adsorbents, Carbopack B, Tenax-GC, and XAD-2, in a SPE and GC analytical method for sampling and determining some persistent organic pollutants such as benzene, toluene, o-, m-, and p-xylenes, naphthalene, anthracene, fluorene, fluoranthene

Sorafenib in radioactive iodine-refractory, locally advanced or metastatic differentiated thyroid cancer: a randomised, double-blind, phase 3 trial.

Marcia S Brose et al.

Lancet (London, England), 384(9940), 319-328 (2014-04-29)

Patients with radioactive iodine ((131)I)-refractory locally advanced or metastatic differentiated thyroid cancer have a poor prognosis because of the absence of effective treatment options. In this study, we assessed the efficacy and safety of orally administered sorafenib in the treatment

Measurement and characterization of insulin-like growth factor binding protein-3 in human biological fluids: discrepancies between radioimmunoassay and ligand blotting.

S E Gargosky et al.

Endocrinology, 131(6), 3051-3060 (1992-12-01)

The inability to detect insulin-like growth factor binding protein-3 (IGFBP-3) in some circumstances by Western ligand blot analysis has emphasized the need to characterize IGFBPs by both ligand binding and immunological techniques. In this study, we have: 1) characterized and

Page 1 of 1